132 related articles for article (PubMed ID: 36475343)
1. Graph Theoretical analysis, in silico modeling and molecular dynamic studies of (5-((2-chloropyridin-4-yl)oxy)-3-phenyl-1H-pyrazol-1-yl)-2-(4-substituted phenyl)-N,N-dimethylethen-1-amine derivatives for the treatment of breast cancer.
Panneerselvam T; Kunjiappan S; Govindaraj S; Gopal M; Natarajan K; Hegde YM; Shanmugam N; Srinivas G; Ravi K; Natarajan V
Anticancer Agents Med Chem; 2022 Dec; ():. PubMed ID: 36475343
[TBL] [Abstract][Full Text] [Related]
2. Functionalized 3-(5-ar-yloxy-3-methyl-1-phenyl-1
Kiran Kumar H; Yathirajan HS; Asma ; Manju N; Kalluraya B; Rathore RS; Glidewell C
Acta Crystallogr E Crystallogr Commun; 2020 May; 76(Pt 5):683-691. PubMed ID: 32431933
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological screening and in silico studies of new N-phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine derivatives as potential antifungal and antitubercular agents.
Nandurkar Y; Bhoye MR; Maliwal D; Pissurlenkar RRS; Chavan A; Katade S; Mhaske PC
Eur J Med Chem; 2023 Oct; 258():115548. PubMed ID: 37307623
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel (Z)-5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)-3-((1-substituted phenyl-1H-1,2,3-triazol-4-yl)methyl)thiazolidine-2,4-diones: a potential cytotoxic scaffolds and their molecular modeling studies.
Subhashini NJP; Kumar KP; Kumar EP; Shravani P; Singh SS; Vani T; Vijjulatha M
Mol Divers; 2021 Nov; 25(4):2017-2033. PubMed ID: 32361888
[TBL] [Abstract][Full Text] [Related]
5. Identification of potent anticancer copper(ii) complexes containing tripodal bis[2-ethyl-di(3,5-dialkyl-1H-pyrazol-1-yl)]amine moiety.
Massoud SS; Louka FR; Dial MT; Malek AJ; Fischer RC; Mautner FA; Vančo J; Malina T; Dvořák Z; Trávníček Z
Dalton Trans; 2021 Sep; 50(33):11521-11534. PubMed ID: 34346447
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and anti-breast cancer activity of new 4-aminoantipyrine-based heterocycles.
Ghorab MM; El-Gazzar MG; Alsaid MS
Int J Mol Sci; 2014 May; 15(5):7539-53. PubMed ID: 24798749
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization, and Biological Study of 3-Trifluoromethylpyrazole Tethered Chalcone-Pyrrole and Pyrazoline-Pyrrole Derivatives.
Kisan Rasal N; Bhaskar Sonawane R; Vijay Jagtap S
Chem Biodivers; 2021 Oct; 18(10):e2100504. PubMed ID: 34409724
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and insecticidal activity of diacylhydrazine derivatives containing a 3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole scaffold.
Wang Y; Xu F; Yu G; Shi J; Li C; Dai A; Liu Z; Xu J; Wang F; Wu J
Chem Cent J; 2017 Jun; 11(1):50. PubMed ID: 29086837
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents.
Hafez HN; El-Gazzar ABA
Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, anticancer evaluation and docking studies of novel 2-(1-isonicotinoyl-3-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one derivatives as Aurora-A kinase inhibitors.
Beniwal M; Jain N; Jain S; Aggarwal N
BMC Chem; 2022 Aug; 16(1):61. PubMed ID: 35978438
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Anti-Cancer Activity of New Pyrazolinyl-Indole Derivatives: Pharmacophoric Interactions and Docking Studies for Identifying New EGFR Inhibitors.
Khalilullah H; Agarwal DK; Ahsan MJ; Jadav SS; Mohammed HA; Khan MA; Mohammed SAA; Khan R
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742992
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and antibacterial activity of 2-[1-(5-chloro-2-methoxy-phenyl)-5-methyl-1H-pyrazol-4-yl]-5-(substituted-phenyl)-[1,3,4]oxadiazoles.
Rai NP; Narayanaswamy VK; Shashikanth S; Arunachalam PN
Eur J Med Chem; 2009 Nov; 44(11):4522-7. PubMed ID: 19640616
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents.
Alam R; Wahi D; Singh R; Sinha D; Tandon V; Grover A; Rahisuddin
Bioorg Chem; 2016 Dec; 69():77-90. PubMed ID: 27744115
[TBL] [Abstract][Full Text] [Related]
15. Ethyl 2-{[5-(3-chloro-phen-yl)-1-phenyl-1H-pyrazol-3-yl]-oxy}acetate.
Yang XL
Acta Crystallogr Sect E Struct Rep Online; 2012 Jan; 68(Pt 1):o123. PubMed ID: 22259411
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, DNA binding and in-vitro cytotoxicity studies on novel bis-pyrazoles.
Indrasena Reddy K; Aruna C; Manisha M; Srihari K; Sudhakar Babu K; Vijayakumar V; Sarveswari S; Priya R; Amrita A; Siva R
J Photochem Photobiol B; 2017 Mar; 168():89-97. PubMed ID: 28189845
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole-Indole Hybrids.
Hassan AS; Moustafa GO; Awad HM; Nossier ES; Mady MF
ACS Omega; 2021 May; 6(18):12361-12374. PubMed ID: 34056388
[TBL] [Abstract][Full Text] [Related]
18. 4-[(4-Chloro-phen-yl)(5-hydr-oxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)meth-yl]-5-methyl-2-phenyl-1H-pyrazol-3(2H)-one.
Fun HK; Jebas SR; Girish KS; Kalluraya B
Acta Crystallogr Sect E Struct Rep Online; 2008 Nov; 64(Pt 12):o2301-2. PubMed ID: 21581279
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II).
Yılmaz Ö; Bayer B; Bekçi H; Uba AI; Cumaoğlu A; Yelekçi K; Küçükgüzel ŞG
Med Chem; 2020; 16(6):735-749. PubMed ID: 31203805
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and antimicrobial activity of some novel benzimidazole derivatives.
Krishnanjaneyulu IS; Saravanan G; Vamsi J; Supriya P; Bhavana JU; Sunil Kumar MV
J Adv Pharm Technol Res; 2014 Jan; 5(1):21-7. PubMed ID: 24696814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
